Oscar Health Inc (OSCR)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $9.65B
Last updated: Nov 17, 2026 at 11:06 AM ET
Oscar Health Inc (OSCR) Earnings: Report Dates and Results
Oscar Health (OSCR) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Oscar Health reported EPS of $0.49, above the -$0.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OSCR has an expected report date of Feb 8, 2027.
OSCR Earnings Call
The latest OSCR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 24 quarters below that had an estimate, OSCR beat 12 and missed 12. Revenue for the quarter ended Sep 30, 2026 was $5.14B, up 71.9% from $2.99B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.49 | -$0.11 | -$0.40 - $0.07 | +545.45% | Beat | N/A | 7 | 4 up, 1 down | Nov 5, 2026 | $5.14B |
| Jun 30, 2026 | $1.10 | $0.43 | -$0.18 - $0.66 | +155.81% | Beat | N/A | 10 | 3 up, 1 down | Aug 6, 2026 | $4.88B |
| Mar 31, 2026 | $2.07 | $1.10 | $0.26 - $1.75 | +88.18% | Beat | +125.0% | 7 | 3 up, 1 down | May 6, 2026 | $4.65B |
| Dec 31, 2025 | -$1.24 | -$0.92 | -$1.07 - -$0.83 | -34.78% | Miss | N/A | 8 | 5 up, 1 down | Feb 10, 2026 | $2.81B |
| Sep 30, 2025 | -$0.53 | -$0.58 | -$0.96 - -$0.40 | +8.62% | Beat | N/A | 7 | 0 up, 3 down | Nov 6, 2025 | $2.99B |
| Jun 30, 2025 | -$0.89 | -$0.84 | -$0.90 - -$0.74 | -5.95% | Miss | -545.0% | 3 | 0 up, 3 down | Aug 6, 2025 | $2.86B |
| Mar 31, 2025 | $0.92 | $0.81 | $0.67 - $1.03 | +13.58% | Beat | +48.4% | 4 | 1 up, 1 down | May 7, 2025 | $3.05B |
| Dec 31, 2024 | -$0.62 | -$0.58 | -$0.68 - -$0.48 | -6.90% | Miss | N/A | 5 | 2 up, 3 down | Feb 4, 2025 | $2.39B |
| Sep 30, 2024 | -$0.22 | -$0.18 | -$0.23 - -$0.05 | -22.22% | Miss | N/A | 7 | 0 up, 0 down | Nov 7, 2024 | $2.42B |
| Jun 30, 2024 | $0.20 | $0.16 | $0.12 - $0.19 | +25.00% | Beat | N/A | 6 | 1 up, 0 down | Aug 7, 2024 | $2.22B |
| Mar 31, 2024 | $0.62 | $0.27 | $0.22 - $0.33 | +129.63% | Beat | N/A | 5 | 0 up, 0 down | May 7, 2024 | $2.14B |
| Dec 31, 2023 | -$0.66 | -$0.70 | -$0.74 - -$0.69 | +5.71% | Beat | N/A | 4 | 0 up, 0 down | Feb 7, 2024 | $1.43B |
| Sep 30, 2023 | -$0.29 | -$0.47 | -$0.57 - -$0.43 | +38.30% | Beat | N/A | 5 | 0 up, 0 down | Nov 7, 2023 | $1.44B |
| Jun 30, 2023 | -$0.07 | -$0.16 | -$0.43 - -$0.03 | +56.25% | Beat | N/A | 4 | 1 up, 0 down | Aug 8, 2023 | $1.52B |
| Mar 31, 2023 | -$0.18 | -$0.09 | -$0.10 - $0.02 | -100.00% | Miss | N/A | 4 | 0 up, 0 down | May 9, 2023 | $1.47B |
| Dec 31, 2022 | -$1.05 | -$1.19 | -$1.41 - -$0.78 | +11.76% | Beat | N/A | 5 | 0 up, 0 down | Feb 9, 2023 | $995.13M |
| Sep 30, 2022 | -$0.91 | -$0.69 | -$0.80 - -$0.63 | -31.88% | Miss | N/A | 6 | 0 up, 0 down | Nov 8, 2022 | $978.43M |
| Jun 30, 2022 | -$0.53 | -$0.35 | N/A | -51.43% | Miss | N/A | N/A | 0 up, 1 down | Aug 11, 2022 | $1.02B |
| Mar 31, 2022 | -$0.36 | -$0.12 | -$0.45 - -$0.02 | -200.00% | Miss | N/A | 6 | 0 up, 0 down | May 10, 2022 | $972.76M |
| Dec 31, 2021 | -$0.95 | -$0.73 | -$1.16 - -$0.73 | -30.14% | Miss | N/A | 5 | N/A | Feb 10, 2022 | $496.07M |
| Sep 30, 2021 | -$1.02 | -$0.65 | -$0.69 - -$0.60 | -56.92% | Miss | N/A | 4 | N/A | Nov 10, 2021 | $443.98M |
| Jun 30, 2021 | -$0.35 | -$0.47 | -$0.53 - -$0.41 | +25.53% | Beat | N/A | 5 | N/A | Aug 12, 2021 | $529.28M |
| Mar 31, 2021 | -$0.75 | -$0.54 | N/A | -38.89% | Miss | N/A | N/A | N/A | May 13, 2021 | $369.39M |
| Dec 31, 2020 | -$1.22 | -$1.17 | N/A | -4.27% | Miss | N/A | N/A | N/A | Mar 4, 2021 | $187.63M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.74, after -$0.02 the year before. It was -$1.22 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.74 | N/A |
| Dec 31, 2024 | -$0.02 | N/A |
| Dec 31, 2023 | -$1.20 | N/A |
| Dec 31, 2022 | -$2.85 | N/A |
| Dec 31, 2021 | -$3.07 | N/A |
| Dec 31, 2020 | -$1.22 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,225 | 13 | |
| 2026Q2 | Jun 30, 2026 | 5,768 | 15 | |
| 2026Q1 | Mar 31, 2026 | 5,052 | 13 | |
| 2025Q4 | Dec 31, 2025 | 7,678 | 13 | |
| 2025Q3 | Sep 30, 2025 | 6,752 | 13 | |
| 2025Q2 | Jun 30, 2025 | 4,503 | 9 | |
| 2025Q1 | Mar 31, 2025 | 4,458 | 12 | |
| 2024Q4 | Dec 31, 2024 | 5,469 | 10 |
2026Q3 Earnings Call
Opening remarks
Mark Bertolini CEO Address consumer needs, including opportunities created by competitor exits. These strengths, combined with our medical cost management, operating efficiency, and superior technology, will drive sustainable financial performance in 2027 and beyond. Now I will review our business highlights. Oscar Insurance ended the third quarter with 2.7 million members, up 27% year-over-year. We are entering open enrollment with a 24% larger footprint spanning 713 counties. We are also expanding into South Carolina. Our expansion increases our total addressable market to approximately 10 million consumers across 21 states. Oscar is launching a new wave of consumer lifestyle products. Our newest product, RetireEase, is live in select markets and serves a growing segment of 2.5 million early retirees in the ACA. Members keep their trusted doctors and receive set prices for preventive services, physical therapy, and heart, bone, and joint care. We are also addressing affordability through bundled benefits. Hundreds of Oscar plans now include dental and vision coverage. In addition, our new Allstate Health Solutions partnership pairs Oscar plans with low-cost supplemental coverage to help bronze members manage out-of-pocket costs. Each product meets a distinct consumer need and extends our reach into high-value, underserved segments. Our Oscar team is also scaling CHOICE. Our Hy-Vee Health with Oscar product is expanding from Iowa into Nebraska, Missouri, and Kansas. This product's concierge care model earns a 92% satisfaction rate and can now serve more small businesses, part-time employees, and gig workers. We are also launching HelloMeno off-exchange to better serve women across the workforce. Employer demand is building. CHOICE adoption is growing fastest in health care, technology, construction, and manufacturing sectors across Oscar states. Oscar's health technology puts consumers in control of their health care decisions across two platforms. The Oscar platform now includes new AI capabilities that make our product suite easy to understand. The Lucie platform serves the broader market, personalizing the health care shopping experience at scale. Lucie instantly matches consumers with plans from major ACA carriers and select supplemental carriers and guides brokers through CMS eligibility. No other platform brings these capabilities together in one place. Lucie is on track to sell approximately 800,000 new policies in 2027, driven by growing broker and consumer demand. Oscar Health's third-quarter performance puts us on track to deliver strong results one year ahead of plan. Our disciplined pricing, product innovation, and technology-powered support are delivering superior member experiences and efficiency across the company. The individual market opportunity is growing. People expect health care to work like the best consumer products: simple, transparent, and personalized. We are building a consumer health care company that meets those expectations and serves a much larger market. The team is positioned to grow market share.
Frequently Asked Questions About OSCR
When is Oscar Health's next earnings date?
Oscar Health's next earnings report is expected for Feb 8, 2027.
Did OSCR beat earnings estimates last quarter?
Yes. Oscar Health reported EPS of $0.49 for the quarter ended Sep 30, 2026, above the -$0.11 estimate, a 545.45% surprise.
What EPS do analysts expect from OSCR next quarter?
The consensus EPS estimate for Oscar Health for the quarter ending Dec 31, 2026 is -$1.12 from 14 analysts, with estimates from -$1.21 to -$1.03.
How often does OSCR beat earnings estimates?
Oscar Health beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +95.50%.
OSCR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors